Garcinia Cambogia (kokum)

Used as a food preservative and souring agent in South and Southeast Asian cuisines; folk remedies include treatments for digestive complaints, inflammation and as an adjunct in weight-control foods. Modern interest centers on extracts from the rind for weight-loss supplements.

• Hydroxycitric acid (HCA) main active organic acid (often 20–60% of extracts); defined as the primary compound studied for metabolic effects.
• Garcinol (a benzophenone derivative), xanthones and other polyphenols present in smaller amounts; garcinol has biological activity relevant to antioxidant and enzyme-interaction effects.

• ATP-citrate lyase inhibition: HCA is a competitive inhibitor of ATP-citrate lyase (also called citrate lyase), an enzyme involved in converting citrate to acetyl-CoA reducing substrate availability for de novo fatty-acid and cholesterol synthesis. This is the principal biochemical mechanism proposed to blunt lipogenesis.
• Appetite / satiety modulation: Animal and some human data suggest HCA may increase glycogen synthesis and modulate neurotransmitters (serotonin), which might reduce appetite in certain settings. Evidence here is mixed and mechanistic links remain incompletely resolved.
• Other actions: Antioxidant/anti-inflammatory activity (polyphenols/garcinol) and possible effects on glucose metabolism/insulin sensitivity have been reported in preclinical and small clinical studies.

Short summary: The strongest, repeatedly studied clinical claim is short-term weight loss. Meta-analyses of randomized trials find a small average weight loss advantage for Garcinia/HCA vs placebo; clinical relevance is modest and results across studies are inconsistent. Safety concerns (rare but serious liver injury reports) temper recommendations.

Details and evidence:

1. Weight loss / obesity

• A widely cited meta-analysis found a small, statistically significant average weight loss favoring HCA over placebo (mean difference ≈ −0.88 kg) across pooled trials, but clinical relevance was questioned and adverse events (GI upset) were reported. Subsequent reviews reach similar conclusions possible short-term, modest benefit for some people but inconsistent and often small.
• More recent randomized and controlled trials show mixed results some show modest reductions in weight/BMI and waist circumference; others show no meaningful benefit when study quality, dose, and co-interventions vary. Overall evidence is low–moderate quality and effect sizes are small.

2. Appetite suppression / caloric intake:

• Some trials report reduced appetite or food intake in the short term (often with 500 mg HCA doses taken before meals), but appetite findings are inconsistent and depend on dose, formulation and participant characteristics.

3. Metabolic effects (lipids, glucose, insulin):

• Animal studies and some small human trials suggest potential improvements in triglycerides, cholesterol and insulin sensitivity, but evidence is preliminary. Combination products (e.g., Garcinia + glucomannan) sometimes show metabolic changes in trials, but isolating Garcinia’s role is difficult. Larger, rigorous human trials are needed.

Other proposed uses (inflammation, antioxidant): mostly preclinical/early clinical; insufficient human evidence to support routine use for these indications. **

• Pregnancy and breastfeeding insufficient safety data; generally advised not to use.
• Active liver disease or history of liver injury avoid (reports of acute liver injury linked to supplements).
• Children and adolescents safety not established; generally avoid.

• Common / mild: gastrointestinal upset (nausea, diarrhea), headache, dizziness. These were the common adverse events in clinical trials.
• Serious (rare): hepatotoxicity multiple case reports and reviews link Garcinia-containing supplements with acute liver injury, in rare instances leading to acute liver failure and transplantation. While rare, these reports mean clinicians and users should be cautious, especially if symptoms like jaundice, dark urine, severe fatigue or abdominal pain occur.
• Neuropsychiatric / serotonin-related: case reports describe serotonin syndrome or serotonin toxicity when Garcinia products were combined with SSRIs/SNRIs probably via serotonin-modulating effects of extracts in some formulations. Use caution with serotonergic medications.

• Serotonergic drugs (SSRIs, SNRIs, MAOIs, certain triptans, etc.) case reports of serotonin toxicity when Garcinia was combined with SSRIs have been published; caution and medical supervision required.
• Drugs metabolized by CYP enzymes / P-glycoprotein constituents such as garcinol may inhibit or modulate cytochrome P450 enzymes and P-gp in vitro, suggesting potential interactions with drugs that have narrow therapeutic indices (e.g., immunosuppressants, anticoagulants, some antiepileptics). Clinical significance is not fully defined; treat with caution and consult clinical pharmacology resources.
• Antidiabetic medications Garcinia may alter glucose or insulin parameters in some studies; there is theoretical risk of hypoglycemia or altered glycemic control when combined with diabetes drugs monitor blood glucose closely.
• Herbs/adaptogens: interactions are possible with other agents that alter liver enzymes or serotonin; e.g., St. John’s wort is an inducer of CYP3A4 (possible complex interactions) required caution when combining multiple supplements. Always check interactions when combining adaptogens or herbals

1. Weight-loss supplement: https://pmc.ncbi.nlm.nih.gov/articles/PMC4053034/
2. Usefulness and Safety Practical safety overview: https://www.nccih.nih.gov/health/garcinia-cambogia
3. Recent advances in Garcinia cambogia nutraceuticals: https://pmc.ncbi.nlm.nih.gov/articles/PMC9352243/

Efficacy: Garcinia cambogia (HCA) may produce a small, short-term weight loss benefit for some individuals, but the effect is modest and inconsistent across trials. It is not a reliable stand-alone long-term obesity treatment. Safety: Generally well tolerated in many trials (GI upset, headache), but rare serious adverse events (acute liver injury) have been reported and warrant caution. There are also case reports of serotonin toxicity when combined with SSRIs. Clinical advice: If someone is considering Garcinia supplements, advise discussing with their clinician, especially if they have liver disease, are pregnant/breastfeeding, take prescription medications (especially serotonergic drugs or medications metabolized by CYPs), or have diabetes. Choose products that clearly list HCA content and avoid long-term unsupervised use.